It may not be looking like a blockbuster term for patent cases at the U.S. Supreme Court, but the intellectual property bar will be watching closely Wednesday when the justices hear Teva Pharmaceuticals USA v. Sandoz. The case could set a precedent requiring the U.S. Court of Appeals for the Federal Circuit to defer to district court claim construction rulings, a move that would shift power from the Federal Circuit and could make it more difficult for lawyers to get patent decisions reversed on appeal.
Claim construction, the interpretation of claims made for a patent, is often a decisive issue in patent litigation. The Federal Circuit currently reverses a large number of district court claim construction rulings.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
